Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Related Citations for PubMed (Select 24508179)

1.

Impact of diabetic retinopathy on late cardiac events after percutaneous coronary intervention.

Tanaka A, Ishii H, Tatami Y, Shibata Y, Osugi N, Ota T, Okumura S, Suzuki S, Inoue Y, Murohara T.

J Cardiol. 2014 Sep;64(3):175-8. doi: 10.1016/j.jjcc.2013.12.006. Epub 2014 Feb 5.

PMID:
24508179
2.

Diabetic retinopathy as a predictor of late clinical events following percutaneous coronary intervention.

Kim YH, Hong MK, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ.

J Invasive Cardiol. 2002 Oct;14(10):599-602.

PMID:
12368513
3.

Long-term prognostic impact of cystatin C on acute coronary syndrome octogenarians with diabetes mellitus.

Fu Z, Xue H, Guo J, Chen L, Dong W, Gai L, Liu H, Sun Z, Chen Y.

Cardiovasc Diabetol. 2013 Nov 1;12:157. doi: 10.1186/1475-2840-12-157.

4.

The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era.

Appleby CE, Ivanov J, Lavi S, Mackie K, Horlick EM, Ing D, Overgaard CB, Seidelin PH, von Harsdorf R, Dzavík V.

Circ Cardiovasc Interv. 2009 Aug;2(4):309-16. doi: 10.1161/CIRCINTERVENTIONS.108.828954. Epub 2009 Jun 30.

5.

Five-year clinical outcomes after implantation of sirolimus-eluting stents in patients with and without diabetes mellitus.

Sato T, Ono T, Morimoto Y, Kawai H, Fuke S, Ikeda T, Saito H.

Cardiovasc Interv Ther. 2012 Sep;27(3):189-95. Epub 2012 Jul 14.

PMID:
22798196
6.

Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction.

Zhang Q, Shen J, Zhang RY, Qiu JP, Lu JD, Zhang Y, Chen YH, Zhang JF, Zhang JS, Hu J, Yang ZK, Zheng AF, Zhang X, Shen WF.

Chin Med J (Engl). 2007 Nov 5;120(21):1862-7.

PMID:
18067756
7.

Comparison of clinical outcomes following acute myocardial infarctions in hypertensive patients with or without diabetes.

Lee MG, Jeong MH, Ahn Y, Chae SC, Hur SH, Hong TJ, Kim YJ, Seong IW, Chae JK, Rhew JY, Chae IH, Cho MC, Bae JH, Rha SW, Kim CJ, Choi D, Jang YS, Yoon J, Chung WS, Cho JG, Seung KB, Park SJ; Other Korea Acute Myocardial Infarction Registry Investigators.

Korean Circ J. 2009 Jun;39(6):243-50. doi: 10.4070/kcj.2009.39.6.243. Epub 2009 Jun 30.

8.

Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).

Girasis C, Farooq V, Diletti R, Muramatsu T, Bourantas CV, Onuma Y, Holmes DR, Feldman TE, Morel MA, van Es GA, Dawkins KD, Morice MC, Serruys PW.

JACC Cardiovasc Interv. 2013 Dec;6(12):1250-60. doi: 10.1016/j.jcin.2013.08.009.

9.

Coronary artery bypass grafting versus coronary implantation of sirolimus-eluting stents in patients with diabetic retinopathy.

Ohno T, Takamoto S, Motomura N, Ono M, Ando J, Morita T, Fujita H, Hirata Y, Nagai R, Shigeeda T, Hirose A.

Ann Thorac Surg. 2007 Nov;84(5):1474-8.

PMID:
17954048
10.

Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Kume K, Yasuoka Y, Adachi H, Noda Y, Hattori S, Araki R, Kohama Y, Imanaka T, Matsutera R, Kosugi M, Sasaki T.

Cardiovasc Revasc Med. 2013 Sep-Oct;14(5):253-7. doi: 10.1016/j.carrev.2013.07.009. Epub 2013 Aug 28.

PMID:
23993293
11.

One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR).

Mieres J, Fernandez-Pereira C, Risau G, Solorzano L, Pauletto R, Rodriguez-Granillo AM, Rubilar B, Stella P, Rodriguez AE.

Cardiovasc Revasc Med. 2012 Sep-Oct;13(5):265-71. doi: 10.1016/j.carrev.2012.06.001. Epub 2012 Jul 15.

PMID:
22796496
12.

[Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].

Wang CH, Xie XJ, Fang Q, Zhang SY, Fang ZJ, Jiang XF, Xie HZ, Liu ZY, Shen ZJ.

Zhonghua Yi Xue Za Zhi. 2011 Jan 25;91(4):265-8. Chinese.

PMID:
21418873
13.

Impact of diabetic retinopathy on cardiac outcome after coronary artery bypass graft surgery: prospective observational study.

Ono T, Ohashi T, Asakura T, Ono N, Ono M, Motomura N, Takamoto S.

Ann Thorac Surg. 2006 Feb;81(2):608-12.

PMID:
16427860
14.

Acute and late clinical outcomes of coronary balloon angioplasty with or without stenting in diabetes--the fact in the "real world".

Leu HB, Chiu TY, Chen JW, Wu TC, Ding PY, Chang MS.

J Chin Med Assoc. 2003 Dec;66(12):699-708.

PMID:
15015818
15.

Timing of invasive strategy in diabetic and non-diabetic patients with non-ST-segment elevation acute coronary syndrome.

Dimitrov NG, Simova II, Mateev HF, Kalpachka MR, Pavlov PS, Tasheva IG.

Folia Med (Plovdiv). 2013 Apr-Jun;55(2):16-25.

PMID:
24191395
16.

The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.

Chen SL, Han YL, Zhang YJ, Ye F, Liu HW, Zhang JJ, Xu B, Jiang TM, Zhou YJ, Lv SZ.

JACC Cardiovasc Interv. 2013 Dec;6(12):1233-41. doi: 10.1016/j.jcin.2013.08.006. Epub 2013 Nov 13.

17.

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.

Mehran R, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B, Henry TD, Kini AS, Stuckey T, Cohen DJ, Berger PB, Iakovou I, Dangas G, Waksman R, Antoniucci D, Sartori S, Krucoff MW, Hermiller JB, Shawl F, Gibson CM, Chieffo A, Alu M, Moliterno DJ, Colombo A, Pocock S.

Lancet. 2013 Nov 23;382(9906):1714-22. doi: 10.1016/S0140-6736(13)61720-1. Epub 2013 Sep 1.

PMID:
24004642
18.

Long-term survival after vascular surgery: specific influence of cardiac factors and implications for preoperative evaluation.

Back MR, Leo F, Cuthbertson D, Johnson BL, Shamesmd ML, Bandyk DF.

J Vasc Surg. 2004 Oct;40(4):752-60.

PMID:
15472605
19.

Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients.

Contini GA, Nicolini F, Fortuna D, Pacini D, Gabbieri D, Vignali L, Valgimigli M, Manari A, Zussa C, Guastaroba P, De Palma R, Grilli R, Gherli T.

Int J Cardiol. 2013 Sep 30;168(2):1028-33. doi: 10.1016/j.ijcard.2012.10.030. Epub 2012 Nov 17.

PMID:
23164591
20.

A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine.

Ari H, Ari S, Erdoğan E, Tiryakioğlu O, Ustündağ Y, Huysal K, Koca V, Bozat T.

Heart Vessels. 2010 Jan;25(1):19-26. doi: 10.1007/s00380-009-1158-x. Epub 2010 Jan 21.

PMID:
20091394
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk